Caxton Associates (UK)’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
Other funds holding THC
GCM
Caxton Associates (UK)'s THC Position: Q2 2026 in Review
Caxton Associates (UK) sold out of Tenet Healthcare (THC) in Q2 2026, closing a stake of 3,435 shares — an estimated $648K sold.
Caxton Associates (UK) first reported a position in THC in Q3 2025 and held it in 3 quarters. The position peaked at $648K in Q1 2026. 678 funds tracked by Wall St. Rank hold THC as of Q2 2026.
- Caxton Associates (UK) reported no remaining Tenet Healthcare position as of Q2 2026 after selling out during the quarter.
- Caxton Associates (UK) sold 3,435 Tenet Healthcare shares in Q2 2026, an estimated $648K.
- Caxton Associates (UK) first reported a position in Tenet Healthcare in Q3 2025 and held it in 3 quarters.
- Caxton Associates (UK)'s Tenet Healthcare position peaked at $648K in Q1 2026.
- 678 funds tracked by Wall St. Rank held Tenet Healthcare as of Q2 2026.
Based on Caxton Associates (UK)'s 13F filing for Q2 2026, filed 14 Aug 2026.